Tuesday, May 27, 2014 5:00 AM
Givat Shmuel, Israel – May 26, 2014 – Cimatron Limited (NASDAQ: CIMT) announced today that dozens of delegates from all continents attended the recent CimatronE Sales Conference in Tel Aviv.
"Cimatron has enjoyed both revenue and profit growth over the past years and this success is largely attributed to our international sales network comprised of both wholly owned subsidiaries as well as independent resellers," said Ira Bareket, Corporate Vice President of Sales and Marketing.
"We have been blessed by an excellent team of professionals around the world who are both friendly and experienced, providing the highest level of service and support to our growing customer base.
"It was overwhelming to witness customer testimonials from all around the world, serving a variety of industries and manufacturing state of the art products – all produced with molds and press tools designed and manufactured using CimatronE.
"The conference presented a great opportunity to expose the new version of our integrated CAD/CAM software, CimatronE 12, which is scheduled for release within a few weeks.
"The conference also gave us the opportunity to update the delegates about Cimatron's current and future development plans, including developments in support of 3D Printing technology."
With over 30 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.
The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
Cimatron's shares are publicly traded on the NASDAQ under the symbol CIMT. For more information, visit http://www.cimatron.com
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
For more information contact:
Chief Financial Officer
Phone: +972 73 237 0114
Idit Pass Lagziel
Phone: +972 73 237 0298
Investor Relations contact:
Ehud Helft/Kenny Green
GK Investor Relations
Tel: (US) 1 646 201 9246